S-100A13 Antibodies

Santa Cruz Biotechnology delivers a wide array of S-100A13 monoclonal antibodies for research applications. S-100A13 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). S-100A13 is a member of the S100 protein family, which plays a crucial role in intracellular calcium signaling and regulation of various cellular processes. S-100A13 influences cell growth, differentiation, and apoptosis, making it significant in cancer research and studies of neurodegenerative diseases. Research has shown that S-100A13 expression levels can vary significantly in different tissue types and disease states. Understanding S-100A13 function and regulation continues to reveal new possibilities for diagnostic and therapeutic strategies. Investigating S-100A13 activity patterns helps researchers better understand cellular signaling pathways and their impact on disease progression. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of S-100A13 and its implications in human health and disease.